Home |
Free Dividend Report |
Stock Splits Calendar |
NVET Historical Stock Prices |
Preferred Stock Newsletter |
Top Option Ideas |
Stock Message Boards |
NVET (NVET) has the following price history information. Looking back at NVET historical stock prices for the last five trading days, on July 25, 2017, NVET opened at $6.71, traded as high as $6.72 and as low as $6.69, and closed at $6.69. Trading volume was a total of 66.10K shares. On July 26, 2017, NVET opened at $6.72, traded as high as $6.72 and as low as $6.69, and closed at $6.71. Trading volume was a total of 50.70K shares. On July 27, 2017, NVET opened at $6.69, traded as high as $6.72 and as low as $6.69, and closed at $6.72. Trading volume was a total of 1.20K shares. On July 28, 2017, NVET opened at $6.69, traded as high as $6.72 and as low as $6.69, and closed at $6.72. Trading volume was a total of 33.50K shares. On July 31, 2017, NVET opened at $6.72, traded as high as $6.72 and as low as $6.72, and closed at $6.72. Trading volume was a total of 0 shares.
NVET Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into NVET shares, starting with a $10,000 purchase of NVET, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 02/06/2015 | |
End date: | 07/31/2017 | |
Start price/share: | $8.96 | |
End price/share: | $6.72 | |
Dividends collected/share: | $0.00 | |
Total return: | -25.00% | |
Average Annual Total Return: | -10.95% | |
Starting investment: | $10,000.00 | |
Ending investment: | $7,501.01 | |
Years: | 2.48 |
NVET Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
07/25/2017 | $6.71 | $6.72 | $6.69 | $6.69 | 66.10K |
07/26/2017 | $6.72 | $6.72 | $6.69 | $6.71 | 50.70K |
07/27/2017 | $6.69 | $6.72 | $6.69 | $6.72 | 1.20K |
07/28/2017 | $6.69 | $6.72 | $6.69 | $6.72 | 33.50K |
07/31/2017 | $6.72 | $6.72 | $6.72 | $6.72 | 0 |
About NVET |
Nexvet Biopharma is clinical-stage biopharmaceutical company focused on transforming the field of companion animal therapeutics by developing and commercializing species-specific biologics. Co.'s platform technology, PETization, is an algorithmic approach that enables it to create monoclonal antibodies, a type of biologic, that are recognized as self or native by an animal's immune system. Co. develops 100.0% species-specific therapeutic biologics in four main areas in veterinary medicine: pain, immuno-oncology (cancer), inflammation, and allergy. Co.'s primary product candidates are in the area of chronic pain: ranevetmab for dogs and frunevetmab for cats. |
NVET Historical Closing Prices | |
Date | Close |
07/25/2017 | $6.69 |
07/26/2017 | $6.71 |
07/27/2017 | $6.72 |
07/28/2017 | $6.72 |
07/31/2017 | $6.72 |
NVET Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.